Evoke Pharma Inc. (EVOK)

[cash_cow1]

We're pulling for her. A family member of mines has the Gastroparesis disease also and the tablet form of metoclopramide is not doing her much good. She is really suffering with this disease. Her upper abdominal stay bloated. It sometimes takes day for her food to be released into her intestines from her stomach. the tablet offer little help. So lets pretension the FDA is they don't pass Gimoti this time around, because the the pain and suffering out weigh the means. Gimoti has been proven to be safe and is a much better form of delivering metoclopramide thorough a nasal spray to treat female patients gastroparesis suffers than tablet form.

Right.